SARS Virus (pathogenicity) And NotAlbert A. Gayle
List of bibliographic references
Number of relevant bibliographic references: 11.Ident. | Authors (with country if any) | Title |
---|---|---|
000183 | Yifei Xu [Royaume-Uni] | Unveiling the Origin and Transmission of 2019-nCoV. |
000216 | Jeannette Guarner | Three Emerging Coronaviruses in Two Decades. |
000222 | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
000240 | Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
000312 | Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian Guo | Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |
000330 | Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
000487 | Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis] | Potential Factors Influencing Repeated SARS Outbreaks in China |
000512 | Julien Riou [Suisse] ; Christian L. Althaus [Suisse] | Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. |
000519 | Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
000542 | Al Giwa [États-Unis] ; Akash Desai [États-Unis] | Novel coronavirus COVID-19: an overview for emergency clinicians |
000830 | Xuan Jiang [République populaire de Chine] ; Simon Rayner [Norvège] ; Min-Hua Luo [République populaire de Chine] | Does SARS-CoV-2 has a longer incubation period than SARS and MERS? |
This area was generated with Dilib version V0.6.33. |